Home > Insider Trading > Filing (0001179110-18-011343)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1034842	Rigel Pharmaceuticals Inc	RIGL	Pharmaceutical Preparations (2834)	943248524

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1686952	Iii C. Eldon Mayer	Rigel Pharmaceuticals, Inc. 1180 Veterans Blvd. South San Francisco CA 94080	Evp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-09-10	50,000	$3.28	165,000	No	4	P	Direct
Common Stock	Acquisiton	2018-09-11	50,000	$3.23	215,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transaction ranging from $3.26 to $3.31. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price.
The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transaction ranging from $3.19 to $3.27. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price.